Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M128,776Revenue (TTM) $M16,757Net Margin (%)33.8Altman Z-Score13.6
Enterprise Value $M125,117EPS (TTM) $2.3Operating Margin %44.2Piotroski F-Score6
P/E(ttm)20.6Beneish M-Score-2.9Pre-tax Margin (%)42.8Higher ROA y-yN
Price/Book16.310-y EBITDA Growth Rate %19.2Quick Ratio1.0Cash flow > EarningsY
Price/Sales7.05-y EBITDA Growth Rate %17.3Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow20.0y-y EBITDA Growth Rate %21.8ROA % (ttm)41.5Higher Current Ratio y-yY
Dividend Yield %2.3PEG1.2ROE % (ttm)88.6Less Shares Outstanding y-yY
Payout Ratio %50.0Shares Outstanding M2,550ROIC % (ttm)154Gross Margin Increase y-yN

Gurus Latest Trades with NVO

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

NVO is held by these investors:



NVO: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about NVO :

Quarterly/Annual Reports about NVO:

    News about NVO:

    Articles On GuruFocus.com
    Novo Nordisk Gets FDA Panel's OK for Diabetes Drug Oct 20 2017 
    Novo Nordisk receives positive 16-0 vote from FDA Advisory Committee in favor of approval for semagl Oct 18 2017 
    Novo Nordisk Receives FDA Approval for Fiasp®, a New Fast-Acting Mealtime Insulin Sep 29 2017 
    Working Mother names Novo Nordisk one of its "100 Best Companies" Sep 26 2017 
    Oramed Now Has a Clear Path to Market With Oral Insulin Sep 22 2017 
    Novo Nordisk announces conclusion of U.S. federal investigation of marketing practices Sep 05 2017 
    Victoza® (liraglutide) is approved in the US as the only type 2 diabetes treatment indicated to red Aug 25 2017 
    3 Companies Aiming to Significantly Reduce Diabetes Treatment Costs Aug 21 2017 
    High-Quality Stocks: Priceline, Nike, Novo Nordisk Jul 28 2017 
    Score Big Returns With Dividend Growth Companies Jul 14 2017 

    More From Our Partners
    Abbvie Inks Immuno-Oncology Deal with Harpoon Therapeutics Oct 20 2017 - ZACKS
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat

    {{numOfNotice}}
    FEEDBACK